Your session is about to expire
← Back to Search
Light Therapy for Autism (TPBMASD Trial)
TPBMASD Trial Summary
This trial will test if a treatment called transcranial photobiomodulation can help reduce symptoms of autism in young children.
TPBMASD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTPBMASD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TPBMASD Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Parents of participants must be aware of the nature of the study.Participants between the ages of 2 and 6 years old, both male and female, of any race.It's okay if you're receiving behavioral therapy while participating in the study. The analysis will take into account the participants receiving therapy in both the control and experimental groups. The study found no problems or conflicts between the therapy and the treatment being studied.You are currently taking medication for mental health reasons.The child who is experiencing a major psychiatric disorder will be allowed to participate in the study, but they must not meet any exclusionary criteria.Parents of participants must be able to communicate with the investigator and study coordinator, and to cooperate with all tests and examinations required by the protocol.Someone who was previously diagnosed with ASD by a professional is someone who was diagnosed with ASD by a professional who is licensed to do so.Most of the participants in both the control and experimental groups are likely to be receiving behavioral therapiesThe child has been engaging in severe self-harming behavior or severe aggressive behavior towards themselves or others in the past week.You are currently taking medication regularly for autism or any other medical condition.You have been diagnosed with another mental or brain disorder, such as epilepsy, or have shown signs of significant mental disorders in the past month.You have any kind of implant in your head, like a stent or a valve.
- Group 1: CognilumTM
- Group 2: Placebo condition
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are participants younger than 45 years of age eligible for this research?
"As per the inclusion criteria for this medical study, only those between 2 and 6 years of age are eligible. The trial boasts 228 studies that involve children under 18-years-old and 42 research projects focusing on patients over 65."
What criteria must an individual fulfill to participate in this research project?
"This autism spectrum disorder study is seeking 30 participants aged between 2 and 6 years old."
What is the total population for this medical trial's enrollment?
"Affirmative. The clinicaltrial.gov website shows that this research study, which was initially announced on November 15th 2020, is still looking for applicants. A total of 30 people are needed across 2 different medical facilities."
Are new participants being accepted into the trial at this time?
"As per the information on clinicaltrials.gov, this medical experiment is actively seeking participants and has been open for application since November 15th 2020 with its most recent update following shortly after on December 7th of that same year."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Dr. Steingold Psychology PC: < 24 hours
Average response time
- < 1 Day
Share this study with friends
Copy Link
Messenger